Blog Post Biotech Consulting Services Paving the Way for Personalized Medicine Yesterday, an FDA panel started writing the first chapter in the new novel of modern medicine. With a unanimous recommendation ...
Blog Post Consulting Services Biotech DSCSA Enforcement Delay – What It Means for You On June 30, 2017, the FDA published a draft guidance announcing an enforcement delay for the pharmaceutical manufacturer’s requirement under ...
Blog Post Consulting Services Biotech 2017 Life Sciences Trends Report Over the past decade or more, phrases like “value-based care” and “patient centricity” have evolved to a position of greater ... Download PDF
Blog Post Quality + Compliance Biotech Data Integrity Problems Break Trust, Part 1 Embedded in nearly every quality or regulatory project for Clarkston is a focus on foundational data integrity principles to not ...
Blog Post Consulting Services Biotech A Matter of Trust: The Pricing Tipping Point in Pharma Trust (trəst) noun – the firm belief in the reliability, truth, ability, or strength of someone or something. Not necessarily ...
Blog Post Consulting Services Biotech Is Your LIMS Master Data Green? [Reduce] In addition to working with some of the most innovative companies in the life sciences industry, one of the greatest ...
Blog Post Consulting Services Biotech Is Your LIMS Master Data Green? In addition to working with some of the most innovative companies in the life sciences industry, one of the greatest ...
Multimedia Generics Biotech Biosimilar Adoption in the United States Although biosimilars have been widely adopted in highly regulated markets, including Europe, Canada, Australia, and Japan, the first biosimilar drug in ... Download PDF
Multimedia Consulting Services Biotech 2016 Life Sciences Outlook While increased healthcare spend will likely lead to higher revenues for manufacturers, life sciences companies will focus heavily on addressing ... Download PDF
Article Medical Device Biotech Healthcare Focus Shifting to Performance, Not Just Pricing As pharmaceutical companies introduce new therapies to the U.S. market, they respond to risk-sharing agreements (RSAs) from healthcare providers, which ...
Article Consulting Services Biotech Developing Data Strategies for the Future Developing data strategies for the storage, analysis and protection of patient-specific data has never been more critical to the future ...
Multimedia Biotech Consulting Services 2015 Biotech Industry Trends As the global population grows increasingly focused on quality of life, many are also taking an active role in monitoring ... Download PDF